NR4A2 and neurodegenerative disease: Correspondingly, promoting Nurr1 activity by overexpression5,6,8,9 or with the early Nurr1 agonist tool amodiaquine (AQ, 1, Chart 1)10,11 had beneficial effects in preclinical models of neurodegenerative diseases.